Protection of PD-1 against LPS-induced endotoxemia and the underlying mechanism.
- Author:
Li-Fen YANG
1
;
Fang HE
;
Jian ZHANG
;
Fei YIN
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Antigens, Surface; physiology; Apoptosis Regulatory Proteins; physiology; Endotoxemia; prevention & control; Female; Interleukin-12; blood; Interleukin-17; blood; Interleukin-1beta; blood; Lipopolysaccharides; toxicity; Mice; Programmed Cell Death 1 Receptor; Tumor Necrosis Factor-alpha; blood
- From: Chinese Journal of Contemporary Pediatrics 2010;12(10):812-815
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVEGram-negative bacteria-induced multiple organ failure/dysfunction syndrome (MOF/MODS) is one of the leading causes of death through the world. The member of immunoglobulin family programmed death-1 (PD-1) is a negative immune regulator. This study investigated the protective effect of PD-1 as well as the underlying mechanism in LPS-induced endotoxemia.
METHODSTen PD-1(+/+) and ten PD-1 knockout (PD-1(-/-)) mice were injected peritoneally with LPS (10 mg/kg), and the survival was observed within 72 hrs after LPS injection. The other 40 PD-1(+/+) and 40 PD-1(-/-) mice were injected peritoneally with LPS (5 mg/kg). Blood samples were collected before injection and 1.5, 3 and 6 hrs after LPS injection (n=10 each time point). Serum levels of various inflammatory mediators were measured using ELISA.
RESULTSThe survival rate in PD-1(-/-) mice was noticeably lower than that in PD-1(+/+) mice after 10 mg/kg LPS injection. Serum levels of inflammatory mediators TNF-α, IL-1β, IL-12 and IL-17 in PD-1/mice were higher than those in PD-1(+/+) mice after 5 mg/kg LPS injection.
CONCLUSIONSPD-1 can protect mice from LPS-induced endotoxemia probably through its regulation on inflammatory mediator production.